摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

furan-2,3-dicarbaldehyde | 7040-07-5

中文名称
——
中文别名
——
英文名称
furan-2,3-dicarbaldehyde
英文别名
2,3-Diformyl-furan
furan-2,3-dicarbaldehyde化学式
CAS
7040-07-5
化学式
C6H4O3
mdl
——
分子量
124.096
InChiKey
AHIXHWRUDZFHEZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    46 °C
  • 沸点:
    276.8±25.0 °C(Predicted)
  • 密度:
    1.298±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.2
  • 重原子数:
    9
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    47.3
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Robba,M.; Zaluski,M.-C., Bulletin de la Societe Chimique de France, 1968, p. 4959 - 4967
    摘要:
    DOI:
  • 作为产物:
    描述:
    3-硼-2-甲酸基呋喃甲酸叔丁基锂对甲苯磺酸 作用下, 以 乙醚 为溶剂, 反应 30.0h, 生成 furan-2,3-dicarbaldehyde
    参考文献:
    名称:
    Discovery of N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an Agonist of the α7 Nicotinic Acetylcholine Receptor, for the Potential Treatment of Cognitive Deficits in Schizophrenia:  Synthesis and Structure−Activity Relationship
    摘要:
    N-[(3R)-1-Azabicyclo[2.2.2] oct-3-yl] furo[2,3-c]pyridine-5-carboxamide (14, PHA-543,613), a novel agonist of the alpha 7 neuronal nicotinic acetylcholine receptor (alpha 7 nAChR), has been identified as a potential treatment of cognitive deficits in schizophrenia. Compound 14 is a potent and selective alpha 7 nAChR agonist with an excellent in vitro profile. The compound is characterized by rapid brain penetration and high oral bioavailability in rat and demonstrates in vivo efficacy in auditory sensory gating and, in an in vivo model to assess cognitive performance, novel object recognition.
    DOI:
    10.1021/jm0602413
点击查看最新优质反应信息

文献信息

  • Substituted 7-aza[2.2.1]bicycloheptanes for the treatment of disease
    申请人:——
    公开号:US20030105089A1
    公开(公告)日:2003-06-05
    The invention provides compounds of Formula I: 1 which may be in the form of pharmaceutical acceptable salts or compositions, are useful in treating diseases or conditions in which &agr;7 nicotinic acetylcholine receptors (nAChRs) are known to be involved.
    这项发明提供了Formula I的化合物: 1 这些化合物可以是药用可接受的盐或组合物的形式,对治疗涉及α7尼古丁型乙酰胆碱受体(nAChRs)的疾病或症状是有用的。
  • Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease
    申请人:——
    公开号:US20030045540A1
    公开(公告)日:2003-03-06
    The invention provides compounds of Formula I: 1 where in W is 2 These compounds may be in the form of pharmaceutical salts or compositions, racemic mixtures, or pure enantiomers thereof. The compounds of Formula I are useful to treat diseases or conditions in which &agr;7 is known to be involved.
    这项发明提供了Formula I的化合物: 其中W为 这些化合物可以是药用盐或组合物的形式,也可以是消旋混合物或其纯对映体。Formula I的化合物可用于治疗已知涉及α7的疾病或症状。
  • [EN] PRODUCTION OF TRI-METHYL BENZENE DERIVATIVES<br/>[FR] PRODUCTION DE DÉRIVÉS DE BENZÈNE TRI-MÉTHYLE
    申请人:RHODIA OPERATIONS
    公开号:WO2018229237A1
    公开(公告)日:2018-12-20
    The present invention relates to the production of tri-functional aromatic molecules from diformylfuran, in particular to the production of tri-methyl benzene derivatives such as for example trimellitic acid or 1,2,4-tri(aminomethyl)benzene from diformylfuran and its derivatives.
    本发明涉及从二甲基甲酰呋喃生产三官能芳香分子,特别是从二甲基甲酰呋喃及其衍生物生产三甲苯衍生物,例如三羧基苯甲酸或1,2,4-三(氨甲基)苯。
  • [EN] PROCESS FOR REDUCTIVE AMINATION OF α,β-UNSATURATED CARBONYL COMPOUND<br/>[FR] PROCÉDÉ D'AMINATION RÉDUCTRICE D'UN COMPOSÉ CARBONYLE α,β-INSATURÉ
    申请人:RHODIA OPERATIONS
    公开号:WO2020034058A1
    公开(公告)日:2020-02-20
    A process for the reductive amination of an α,β-unsaturated carbonyl compound and a process for the preparation of a tetrathydrofuran-derived amine starting from furfural or a derivative thereof.
    一种用于α,β-不饱和羰基化合物的还原胺化的方法,以及一种从糠醛或其衍生物出发制备四氢呋喃衍生胺的方法。
  • [EN] NOVEL BIO-BASED DIOLS FROM SUSTAINABLE RAW MATERIALS, USES THEREOF TO MAKE DIGLYCIDYL ETHERS, AND THEIR COATINGS<br/>[FR] NOUVEAUX DIOLS D'ORIGINE BIOLOGIQUE À PARTIR DE MATIÈRES PREMIÈRES RENOUVELABLES, LEURS UTILISATIONS POUR LA FABRICATION D'ÉTHERS DIGLYCIDYLIQUES, ET LEURS REVÊTEMENTS
    申请人:NDSU RES FOUNDATION
    公开号:WO2021007171A1
    公开(公告)日:2021-01-14
    The invention relates to diols derived from 5-hydroxymethyl furfural, diformyl furan, or derivatives thereof. The invention further relates to diglycidyl ethers derived from the diols of the invention, curable coating compositions containing the diglycidyl ethers, and objects coated with the curable coating compositions. The invention also relates to composites, composites, adhesives, and films containing the diglycidyl ethers of the invention. The invention also relates to methods of making the diols, diglycidyl ethers, and curable coating compositions.
    该发明涉及从5-羟甲基糠醛、二甲酰呋喃或其衍生物衍生的二元醇。该发明还涉及从该发明的二元醇衍生的二环氧乙烷醚,含有该二环氧乙烷醚的可固化涂料组合物,以及涂有该可固化涂料组合物的物体。该发明还涉及含有该发明的二环氧乙烷醚的复合材料、胶粘剂和薄膜。该发明还涉及制备二元醇、二环氧乙烷醚和可固化涂料组合物的方法。
查看更多